AUSTIN, Texas--(EON: Enhanced Online News)--Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that Todd Newton, Chief Executive Officer, and Stefanie Cavanaugh, Chief Financial Officer, are scheduled to participate at the 29th Annual ROTH Conference in Dana Point, CA. The conference will allow institutional investors to meet with Mr. Newton and Ms. Cavanaugh and will include a formal presentation.
Event: 29th Annual ROTH Conference
Date: Monday, March 13, 2017
Time: 12:30 pm PT / 3:30 pm ET
Presenter: Todd Newton, Chief Executive Officer
An audio webcast of the Company’s presentation will be available online at www.apolloendo.com. A replay of the presentation will be available for 90 days.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today.
Apollo’s common stock is traded on NASDAQ Global Market under the symbol "APEN." For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.